Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

Resolves the same as the original on Metaculus.

Resolution criteria

This question will resolve as Yes if either the US Food and Drug Administration or the European Medicines Agency withdraw approval for semaglutide (AKA Wegovy, Ozempic, or any other brand name for semaglutide) before January 1, 2025. The stated reason for withdrawal must include concerns of safety or harmful side effects.

Fine print and additional background information can be found on Metaculus.

Once the original resolves, its resolution will be applied to this market automatically. Trustworthy-ish users are encouraged to resolve this market before then if the outcome is known and unambiguous. Feel free to ping @jskf to request early resolution or to report issues.